Long‐lasting Correction of in Vivo LTP and Cognitive Deficits of Mice Modelling Down Syndrome With an Α5‐selective GABAA Inverse Agonist
British Journal of Pharmacology - United States
doi 10.1111/bph.14903
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2020
Authors
Publisher
Wiley